Discover the complete record of transactions filed by 이명재, Chief Executive Officer. Insider active across 2 companies, notably 인바이오. Cumulatively, 5 disclosures have been published. The latest transaction was disclosed on 27 March 2026 — Purchase. Regulator: DART (FSS). All data is openly available.
Lee Myung-jae is the Chief Executive Officer at 인바이오. He is responsible for the strategic and operational direction of the company. With significant experience in the sector, he plays a key role in innovation and product development. His leadership is essential for ensuring the growth and competitiveness of 인바이오.